Nurses Arena Forum

General Category => News => Topic started by: katty on June 12, 2018, 03:10:45 PM

Title: @Fmohnigeria Memo on FDA Approval Of Swiss Pharma Kymraih Cell Therapy For Cance
Post by: katty on June 12, 2018, 03:10:45 PM
ALL CMDs
ALL MDs
 
RE: UNITED STATES FOR FOOD AND DRUG ADMINISTRATION APPROVES KYMRIAH CELL THERAPY FOR TREATMENT OF CANCER
 
The Office of the Secretary to the Government of the Federation has written to inform the Ministry that the Swiss Pharmaceutical Company, Novartis had on 1st May, 2018 in Basel disclosed that the United States Food and Drug Administration (FDA) approved its Kymriah cell therapy for treatment of patients with large B-Cell Lymphoma and as a one (1) time treatment for acute lymphoblastic leukaemia, the most common childhood cancer in the United States (copy attached).
 
2. You are to bring the contents of this circular to all relevant department in your hospital for their information and necessary action.
 
3. Please, accept the assurances of the best regards of the Honourable Minister.
 
Signed:
Dr. O.J. Amedu, mni
Head, Department of Hospital Services
For: Honourable Minister
(http://medicalworldnigeria.com/files/images/12.jpeg)